Random

neuropsychopharmacology

This image shows a psilocybe mexicana mushroom in a field.

·May 7, 2014·3 min read

Psilocybin Inhibits the Processing of Negative Emotions in the Brain

A new study reports psilocybin influences the amygdala, weakening the processing of negative stimuli. Researchers hope the finding could pave the way for new treatment approaches for some psychiatric disorders.

Featured Neuroscience Psychology

·March 30, 2018·5 min read

Opioid Use Prevalent Among Electronic Dance Music Partygoers

Researchers report 10 percent of people who have attended EDM events have misused opioids in the past 12 months. The number, researchers say, exceeds national averages. Oxycontin was reported to be the most widely misused drug within the scene.

Featured Neuroscience Psychology

·November 19, 2021·5 min read

Psychedelics Show Promise in Treating Mental Illness

A growing body of evidence suggests psychedelics including psilocybin and LSD show promise in providing lasting relief from symptoms for those suffering some mental health disorders. Researchers found DOI, a similar drug to LSD, reduced negative behavioral responses following fear triggers in mouse models of anxiety.

Featured Psychology

·March 16, 2018·4 min read

Study Casts Doubt on Ketamine Nasal Sprays for Depression

A new study reports intranasal delivery of ketamine may cause problematic side effects for some people with depression.

Image shows brain scans showing how both placebos and antidepressants affect the brain.

Featured Psychology

·September 30, 2015·7 min read

Depressed People Who Respond to Placebos Get The Most Help From Real Medications

A new study reports how well people with depression respond to placebos may determine how well they will respond to antidepressant medications.

Image shows a woman sitting at a table and two transparent men.

Featured Psychology

·February 3, 2016·4 min read

An Alternative Treatment Target For Schizophrenia

A new study suggests that dysregulation in the way two G protein-coupled receptors talk to each other may be responsible for some symptoms of schizophrenia.

Image shows Psilocybe allenii mushrooms.

Brain Cancer Featured Neuroscience Psychology

·December 10, 2015·1 min read

Magic Mushroom Component Reduces Depression and Anxiety in Cancer Patients

Study suggests that a single dose of psilocybin, the active ingredient of magic mushrooms, may be enough to produce a lasting decrease in depression and anxiety for cancer patients.

1 … 12 13 14

neuropsychopharmacology

Psilocybin Inhibits the Processing of Negative Emotions in the Brain

Opioid Use Prevalent Among Electronic Dance Music Partygoers

Psychedelics Show Promise in Treating Mental Illness

Study Casts Doubt on Ketamine Nasal Sprays for Depression

Depressed People Who Respond to Placebos Get The Most Help From Real Medications

An Alternative Treatment Target For Schizophrenia

Magic Mushroom Component Reduces Depression and Anxiety in Cancer Patients

Jamais Vu: When the Familiar Turns Eerily New

New Tools Illuminate Myelin Growth in Infants

From Vinyl to Visions: Fruit Flies Showcase Decision-Making Prowess

Jellyfish Show Remarkable Learning Skills

Subscribe